EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS

被引：0
|
作者：
Adunlin, G. [1 ]
Dranitsaris, G. [2 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Augmentium Pharma Consulting Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1536
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN203
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [21] Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation
    Fabregat Franco, Carles
    Castet, Florian
    La Casta, Adelaida
    Adeva, Jorge
    Castillo, Alfredo
    Munoz, Andres
    Peinado, Paloma
    Martinez de Castro, Eva
    Lobo, Miriam
    Granja, Monica
    Maria Rodriguez-Alonso, Rosa
    Fernandez Montes, Ana
    Vera, Ruth
    Gallego, Javier
    Grana, Begona
    Ghanem, Ismael
    Ales, Inmaculada
    Molina, Raquel
    Macarulla, Teresa
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [23] Meta-analytic,trial-level approach to validation of progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, R.
    Zietemann, V
    Mattheucci, Gothe R.
    Schwarzer, R.
    Conrads-Frank, A.
    Schnell-Inderst, P.
    Stollenwerk, B.
    Plieschnegger, P.
    Esteban, E.
    Siebert, U.
    VALUE IN HEALTH, 2007, 10 (06) : A342 - A342
  • [24] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
  • [25] Overall survival and progression-free survival in pediatric meningiomas: a systematic review and individual patient-level meta-analysis
    Johannes Wach
    Martin Vychopen
    Alim Emre Basaran
    Marcos Tatagiba
    Roland Goldbrunner
    Erdem Güresir
    Journal of Neuro-Oncology, 2025, 172 (2) : 289 - 305
  • [26] RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (RPFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN CHEMOTHERAPY-NAIVE METASTATIC CASTRATIONRESISTANT PROSTATE CANCER (MCRPC): A CORRELATION META-ANALYSIS
    Leung, L.
    Patel, M.
    Teitsson, S.
    Hofer, K.
    Qian, A.
    Kurt, M.
    VALUE IN HEALTH, 2022, 25 (12) : S28 - S28
  • [27] Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials
    Li, Ling
    Pan, Zhanyu
    CLINICAL BREAST CANCER, 2018, 18 (01) : 63 - 70
  • [28] Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials
    Sidhu, Roger
    Rong, Alan
    Dahlberg, Steve
    CLINICAL CANCER RESEARCH, 2013, 19 (05) : 969 - 976
  • [29] Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis
    Milrod, Charles J.
    Kim, Kang Woo
    Raker, Christina
    Ollila, Thomas A.
    Olszewski, Adam J.
    Pelcovits, Ari
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (06) : 2237 - 2241
  • [30] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Belin, Lisa
    Tan, Aidan
    De Rycke, Yann
    Dechartres, Agnes
    BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1707 - 1714
12345